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Constructs Through Microfluidically Directed
Differentiation of Mesenchymal Stem Cells
Stephen M. Goldman1,2 and Gilda A. Barabino1,3,*
Abstract
The development of tissue engineered osteochondral units has been slowed by a number of technical hurdles
associated with recapitulating their heterogeneous nature ex vivo. Subsequently, numerous approaches with re-
spect to cell sourcing, scaffolding composition, and culture media formulation have been pursued, which have
led to high variability in outcomes and ultimately the lack of a consensus bioprocessing strategy. As such, the
objective of this study was to standardize the design process by focusing on differentially supporting formation
of cartilaginous and bony matrix by a single cell source in a spatially controlled manner within a single material
system. A cell-polymer solution of bovine mesenchymal stem cells and agarose was cast against micromolds of a
serpentine network and stacked to produce tissue constructs containing two independent microfluidic net-
works. Constructs were fluidically connected to two controlled flow loops and supplied with independently
tuned differentiation parameters for chondrogenic and osteogenic induction, respectively. Constructs receiving
inductive media showed differential gene expression of both chondrogenic and osteogenic markers in opposite
directions along the thickness of the construct that was recapitulated at the protein level with respect to colla-
gens I, II, and X. A control group receiving noninductive media showed homogeneous expression of these bio-
markers measured in lower concentrations at both the mRNA and protein level. This work represents an
important step in the rational design of engineered osteochondral units through establishment of an enabling
technology for further optimization of scaffolding formulations and bioprocessing conditions toward the pro-
duction of commercially viable osteochondral tissue products.
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Introduction
The development of engineered tissue grafts has
emerged as a promising therapeutic alternative for
the repair and replacement of organs. A number of ap-
proaches, using a diverse spectrum of scaffolds, cell
populations, and bioprocessing conditions, have been
pursued for the production of such grafts. A plurality
of these efforts has been centered around the develop-
ment of homogenous tissues intended to mimic the
functional properties of the target tissue in vivo.
Some tissues, however, are heterogeneous both struc-
turally and functionally and possess spatially varying
biochemical compositions and mechanical properties
for which the use of a single scaffolding material,
cell source, or bioreactor chamber may be inappro-
priate. A classic example of this is the osteochondral
unit, consisting of a hyaline cartilage layer and the
integrated subchondral bone.
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Osteochondral defects, resulting from traumatic in-
jury, are typically treated through a grafting technique
termed mosaicplasty.2 One of the primary shortcomings
of mosaicplasty is the reliance on autologous graft sourc-
ing from a healthy nonload bearing site that is both lim-
ited in its availability and potentially inappropriate for
repair due to advanced osteoarthritic degeneration.1,2
To address this supply issue, a number of approaches
have been pursued to create a suitable replacement for
the autologous grafts. Common approaches to recapit-
ulate the unique heterogeneity of the osteochondral
unit include the production of composite scaffoldings
loaded with one or more cell sources having chondro-
genic and/or osteogenic potential and cultivating them
utilizing both commercially available and custom-built
bioreactor systems.3 Constructs produced in this man-
ner, however, are still nonoptimal as they suffer from a
number of shortcomings. Arguably, the most pertinent
shortcoming of these approaches is their reliance on
terminally differentiated cells (osteoblasts and chon-
drocytes) isolated from patient-specific biopsies and
expanded in vitro. Use of terminally differentiated
cells is plagued by the same dependency on an available
autologous donor site, as well as low proliferation rates
and potential degradation of functionality, should
in vitro expansion be necessary to sufficiently populate
the tissue engineered construct.4
Mitigation of this particular shortcoming can be ac-
complished by utilizing undifferentiated multipotent
mesenchymal stem cells (MSCs) as a single autologous
cell source for repair of osteochondral defects.3,5–8
MSCs are well-known progenitor cells for both the
chondrocyte and osteoblast lineages, which have been
used to generate osteochondral constructs using single-
component or composite scaffolds across a range of
compositions and material properties.3,6,9–19 The pri-
mary challenge to MSC-based constructs arises from
the need to either utilize costly predifferentiation opera-
tions before the seeding of the construct or simultaneously
modulate differentiation down to distinct lineages in a
unified culture solution. Using conventional bioreactor
systems, the popular approach of supplementing the cul-
ture media with lineage-specific signaling molecules to
achieve directed differentiation of MSC is untenable for
biphasic constructs without some means of spatially di-
rected delivery to prevent dominance of one desired phe-
notype throughout the construct.20
Based on these realities, we hypothesized that the
spatially confined presentation of optimized differenti-
ation cues would result in tissue-specific inductive re-
gions for the regeneration of both bone and cartilage
tissues using a model universal donor cell source in an
integrated tissue construct. To test this hypothesis, we uti-
lized a microfluidic hydrogel platform previously devel-
oped in our laboratory to stimulate region-specific
induction of osteoblastic and chondrogenic phenotypes
through parallel, independent microfluidic networks and
evaluated the constructs after 2 weeks of culture for the
presence of differential gene expression and matrix com-
position between the osteogenic and chondrogenic layers.
Materials and Methods
Supplies and reagents were obtained from VWR Interna-
tional, Sigma, or Invitrogen unless otherwise specified.
Antibodies were from AbD Serotec or Abcam. ELISA
kits for Collagens I and II were purchased from Chon-
drex, Inc. and for Collagen X from MyBioSource, Inc.
MSC isolation and characterization
Bone marrow aspirates from bovine calves (Research
87) were mixed with expansion medium (high-glucose
Dulbecco’s modified Eagle’s medium [DMEM] supple-
mented with 10% certified fetal bovine serum [FBS]
and 1· penicillin–streptomycin–fungizone [PSF]) sup-
plemented with 300 U/mL heparin and subjected to
straining and centrifugation processes. Following centri-
fugation, pelleted cells were suspended in fresh expan-
sion medium and plated onto T-75 flasks (Corning,
Inc.). Nonadherent cells were removed from the flasks
after 24 h, while adherent cells were cultured to conflu-
ence. Subsequent subculturing was carried out to Pas-
sage 3 at a splitting ratio of 1:3. Following Passage 3,
MSCs were placed in a cryoprotective medium (70%
DMEM, 20% FBS, 10% dimethyl sulfoxide [DMSO])
at a concentration of 1 million cells/mL stored in liquid
nitrogen in 1 mL aliquots.
Tissue culture
Constructs were fabricated by casting a cell-polymer so-
lution (25 million MSC/mL; 2.5% agarose) against
plasma-treated PDMS molds of the microfluidic network
as described previously.21 Independent networks were
formed by sealing a planar slab of the cell-polymer solu-
tion between the molded portions in an acrylic casing
(Fig. 1). External flow loops were connected through
luer-lock interfaces on the acrylic casing. Unidirectional
flow of culture media was achieved using a syringe pump
equipped with dual check valves. Capitalizing on the in-
dependence of the fluidic networks, culture commenced
under regionally specific bioprocessing conditions.
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Constructs from the experimental group received two
different sets of bioprocessing conditions. The osteogenic
region was provided with a serum-free basal media (high-
glucose DMEM, 1· PSF, 0.1 lM dexamethasone, 50 lg/
mL ascorbate 2-phosphate, 40 lg/mL L-proline, 100 lg/
mL sodium pyruvate, 1· insulin–transferrin–selenium)
supplemented with 10 ng/mL BMP-2 at a constant per-
fusion rate of 2.5 mL/min such that the shear stress dis-
tribution at the microchannel walls was a uniform 10
dyne/cm2. The chondrogenic region was supplied with
serum-free basal media supplemented with 100 ng/mL
TGF-b3 at 250 lL/min. The flow rate for the chondro-
genic region was determined to both fulfill the minimal
flow rate requirements for the nutrient demands of the
resident cell population21 and to provide a uniform,
low-magnitude shear stress distribution of 1 dyne/cm2
at the microchannel walls. For the control group, both
microfluidic networks of the tissue constructs were pro-
vided with noninductive serum-free basal media at a
flow rate of 250 lL/min flow rate. Total culture media
volume was maintained at 100 mL with fresh media
exchanges performed every 3–4 days. Gas exchange
and pH balance were maintained by bubbling a 5%
CO2 balance air gas mixture through the culture
media reservoir.
mRNA expression
Quantitative reverse transcription polymerase chain
reaction (RT-qPCR) was used to quantify gene expres-
sion within the constructs in a region specific manner.
RNA was isolated from the homogenized cell lysate
according to the TRIzol protocol. Reverse transcrip-
tion of the RNA into cDNA was achieved using a
QuantiTect Rev Transcription Kit (QIAGEN). Real-
Time PCR amplification was performed (StepOne-
Plus; Applied Biosystems) in the presence of SYBR
Green/ROX master mix and primers for target osteo-
chondral lineage markers (Supplementary Table S1).
Regulation of the target genes over day 0 controls
was determined by processing the raw fluorescence
data using LinRegPCR (v12.11; www.hartfaalcentrum
.nl) with glyceraldehyde-3-phosphate dehydrogenase
FIG. 1. Construction process of the microfluidic osteochondral graft. Each target region is independently cast
and controlled through ports in the acrylic casing. The chondrogenic and osteogenic regions are separated by
a planar midsubstance region molded directly into a PDMS gasket, which ensures unidirectional flow through
the microfluidic networks.
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(GAPDH) and b-actin (ACTB) serving as the endoge-
nous controls through geometric averaging.22
Biochemical analyses
Construct weights (wet weight) were taken before freez-
ing (80C) and subsequent lyophilization. Lyophilized
samples were weighed again (dry weight) and digested
in papain buffer for 16 h at 60C. Aliquots of digested
samples were assessed for DNA content using a Pico-
Green dsDNA Kit. Glycosaminoglycan (GAG) content
was measured using the dimethylmethylene blue dye-
binding assay.23 Quantification of collagen types I, II,
and X was carried out using ELISA Kits as per manufac-
turers’ protocols.
Histological analyses
Tissue constructs were fixed in 10% (v/v) neutral-
buffered formalin, dehydrated through an ethanol gradi-
ent, embedded in paraffin wax, and cut into sections of
8.0 lm. Deparaffinized sections were then stained with
Toluidine Blue for proteoglycans and Alizarin Red for
calcium. For immunofluorescence, samples were blocked
for 30 min and incubated with primary rabbit antibodies
(1:100) against collagen types I, II, and X at 4C over-
night following antigen retrieval using the citrate buffer
method. Sections were then washed thrice in PBS
and treated with goat anti-rabbit secondary antibodies
(1:200) for 1 h at room temperature. Sections were
washed once more and mounted with VECTASHIELD
containing DAPI. Photomicrographs were captured
on an inverted fluorescence microscope (Nikon Instru-
ments, Inc.) equipped with a CCD camera (CoolSNAP
HQ2 CCD; Photometrics).
Statistical analysis
Sample sizes for RT-qPCR and biochemical analyses
were n = 3 and n = 5, respectively. Bar graphs are pre-
sented as the mean – SEM with statistically significant
differences defined as p < 0.05 using two-way ANOVA
with Bonferroni post hoc tests for multiple comparisons.
Results
Cellular content
As depicted in Figure 2, there was no significant differ-
ence in DNA content between any of the spatially dis-
tinct regions within either the experimental or control
groups. There was, however, a statistically significant
difference in DNA content between the control and ex-
perimental groups across all phenotypic regions of the
tissue constructs after 2 weeks of culture. This differ-
ence indicates increased cell proliferation within the
experimental group relative to the control group.
Differential expression of osteochondral genes
Within the control group, no difference was ob-
served in the osteogenic (RUNX2, OSTEOCALCIN,
and COL1A1), hypertrophic (COLXA1), or chondro-
genic (SOX9, AGGRECAN, and COL2A1) gene ex-
pression profiles between the various regions of the
tissue constructs. Within the experimental group,
however, differential expression of both the osteogenic
and chondrogenic gene expression profiles with respect
to the opposing construct region was observed (Fig. 3).
Within the osteogenic target region, a statistically sig-
nificant upregulation of RUNX2 (86-fold) and COL1A1
(29-fold) was observed relative to the chondrogenic target
region. Regulation of the osteogenic gene panel was also
greater compared with the chondrogenic panel with the
exception of aggrecan, but not in a statistically significant
manner. With regard to the chondrogenic gene panel, a
statistically significant regulation of the entire chondro-
genic gene panel (SOX9, AGGRECAN, and COL2A1)
within the chondrogenic region was observed relative to
the osteogenic target region of the construct. In addition,
COLXA1 expression was observed to increase across the
construct from the chondrogenic regions to the osteo-
genic region, with a statistically significant difference
in expression occurring between the chondrogenic and
FIG. 2. After 2 weeks of culture, DNA content
was significantly higher in the experimental group,
which received cytokine supplementation relative
to the unsupplemented control group. There were
no significant differences between the various
regions of the experimental cultures. *Indicates a
statistically significant finding (p < 0.05).
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osteogenic regions, but not with such difference occurring
between the midsubstance and osteogenic regions.
GAG content
As evidenced by the results of the DMMB assay, GAG
content was significantly higher in the experimental
group relative to the control group (Fig. 4). In addition,
within the experimental group, GAG content was on av-
erage highest in the chondrogenic target region and lowest
in the osteogenic region. The difference in average GAG
content in the chondrogenic and the osteogenic regions
of the experimental group, however, was not considered
statistically significant. In addition, no statistically signifi-
cant difference in GAG content was observed between the
construct regions of the control groups.
Graded collagen expression
ELISA was performed for expression of collagens Type
I, II, and X. As depicted in Figure 5, all three collagen
types exhibited graded expression across the construct
thickness, with types I and X exhibiting their maximum
concentration in the osteogenic target region of the
construct and type II exhibiting a maximum concen-
tration in the chondrogenic region of the construct.
Within the control group, collagen content was signif-
icantly lower with no gradations of note.
Histology and immunofluorescence
Control constructs stained weakly and relatively ho-
mogeneously for both histological stains and for all
collagens tested following 2 weeks of culture (Fig. 6).
The experimental group, however, exhibited much
stronger staining across all regions. Within the experi-
mental group, Toluidine Blue staining revealed no dis-
cernible difference in proteoglycan content between
the various regions of the osteochondral constructs. Ali-
zarin Red staining revealed a slight gradient in mineral-
ization with a region of high concentration within the
FIG. 3. Differential loading of an osteochondral tissue construct results in gene expression gradients of both
osteogenic and chondrogenic genes. *Indicates a statistically significant finding (p < 0.05).
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osteogenic layer and a region of low concentration in the
chondrogenic layer. Collagen staining revealed a mild
gradient in both type I and type II collagen with the
highest concentration of each located within the osteo-
genic and chondrogenic layers, respectively. Collagen
X staining results were inconclusive between regions
in the experimental group, but clearly higher relative
to the control group.
Discussion
The purpose of the study described herein was to evalu-
ate microfluidic hydrogels as a platform for the produc-
tion of osteochondral tissue constructs through the
spatially directed differentiation of bovine MSCs. The
ability of the mechanochemical inductive cues provided
through the microfluidic networks to direct targeted
phenotype induction was evaluated through gene ex-
pression analysis, biochemical composition, and histo-
logical staining. Relative to our noninductive control
cultures, the spatially defined presentation of inductive
factors and bioprocessing conditions had a clear impact
in proliferation of the resident cell population and elab-
oration of a spatially discrete osteochondral matrix
within our experimental group. On a whole construct
FIG. 4. Measurement of sulfated
glycosaminoglycan content within the various
regions of the osteochondral constructs by
DMMB assay reveals significantly higher GAG
accumulation in the experimental group
irrespective of the construct region relative to the
control group. Within the experimental group,
however, no statistically significant differences
were observed. GAG, glycosaminoglycan.
*Indicates a statistically significant finding (p < 0.05).
FIG. 5. ELISA reveals gradients in Collagen type
I across the osteochondral constructs and
differential expression of collagen types II and X
between the osteogenic and chondrogenic
regions of the experimental group. *Indicates a
statistically significant finding (p < 0.05).
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basis, differences between the control and experimental
constructs included significant increases in both DNA
content and total osteochondral matrix elaboration.
These findings are in agreement with the prior litera-
ture on the effects of the TGF-b superfamily proteins
provided to these cultures,24,25 as well as to previous
findings from our group on the synergistic effects of hy-
drodynamic loading on MSC differentiation efficiency
in the presence of these factors.26 Within the experimen-
tal group, there was evidence of spatial differences in
matrix composition reminiscent of the osteochondral
junction. The chondrogenic target region of the con-
struct showed a local maximum of GAG content and
significantly higher expression of Collagen II relative
to the osteogenic target region, while significantly higher
expression of Collagen I and X was observed in addition
to a minimum in GAG content in the osteogenically tar-
geted region of the constructs. In addition, Alizarin Red
staining showed an increase in mineralization within
the osteogenic region. The dual presence of GAG and
mineralization within the osteogenic region indicates
the concurrent formation of both cartilage and bone,
and may represent an intermediate differentiation step
along the endochondral ossification pathway for the cul-
ture period studied herein, rather than a terminal bone
phenotype. While suboptimal, we believe this result to
be acceptable for the culture durations studied and hy-
pothesize that cultivation for longer durations would re-
sult in replacement of the cartilaginous portion of the
matrix with higher quality bone formation.25,27 This is
further supported by the relatively lower presence of
both Collagen I and mineralization in the chondrogenic
FIG. 6. Immunofluorescence staining shows gradients in collagen types I and II. Alizarin red staining also
indicates increased mineralization within the osteogenic region relative to the chondrogenic region.
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region indicating that this endochondral bone formation
is concentrated near the BMP-2 supply network and
that the cartilage formation in the chondrogenic region
is hyaline in character.
In benchmarking our technology in the context of
other studies, we note that a number of studies have
been reported utilizing dual culture control systems for
osteochondral tissue engineering. Chang et al. cultured
a gelatin-infused sinbone block to generate osteochon-
dral constructs in a dual-chambered bioreactor ap-
proach that validated their scaffolding system for the
production of hyaline cartilage within the gelatin por-
tion of the composite scaffolding.28 The bony portion
of this scaffold, however, was acellular in nature. Mah-
moudifar and Doran used a similar dual-chambered
bioreactor to that implemented by Chang et al. for the
production of osteochondral tissue constructs from
two sutured together polyglycolic acid meshes seeded
with adipose-derived stem cells.29 This approach mir-
rored our results after 2 weeks of culture with respect
to statistically indeterminate differences in GAG content
between the layers, but was not in agreement with our
finding of differential expression of collagen II. Com-
pared to these studies, our constructs are not only cellu-
larized in both the osteogenic and chondrogenic regions
as was also shown by Mahmoudifar and Doran but also
our system was shown to suppress osteogenic character
within the chondrogenic layer. While the characteristics
of the cell type seeded in each of these systems may also
play a role in the improvement shown with respect to
this metric, we believe the improvement is due to im-
proved control of the microenvironment provided by
the presence of the microfluidic network within the tis-
sue construct versus the superficial delivery of inductive
cues characteristic of the dual-chambered bioreactor.
While more involved than the dual-chambered bioreac-
tor, the paradigm proposed by our system offers the ca-
pability to produce thicker constructs as necessary and
even greater opportunities for optimization of culture
conditions through the incorporation of independent
microfluidic networks into the construct.
Conclusions
In this study, we have established a paradigm for the pro-
duction of biphasic tissue constructs through micro-
fluidically directed differentiation of MSCs using the
osteochondral unit as a model tissue. While there is ev-
idence in the literature of other approaches to spatially
engineer the composition of an osteochondral construct,
this study is the first of its kind to utilize microfluidic net-
works to successfully engineer a biphasic tissue of clini-
cally relevant thickness with measurable differences in
biochemical composition between the bony and cartilag-
inous regions. The results presented herein highlight
how an optimized mechanochemical microenvironment
can affect the production of tissue-specific extracellu-
lar matrix of the resident cell population seeded in the
various regions of a hydrodynamically loaded osteo-
chondral construct compared to control constructs pro-
duced through a noninductive bioprocessing scheme.
Based on our results, we believe that this approach
may have significant potential for the production of
the osteochondral unit, as well as other interfacial tis-
sues for use in regenerative capacities. We would be re-
mise, however, if we did not address the dependency
of the ultimate utility of this approach on the further de-
velopment of enabling material and biofabrication tech-
nologies to help achieve cost-effective production and
processing of well-defined robust tissue products. The
promising findings of the present study represent an im-
portant first step in the rational design of engineered
osteochondral units through establishment of a platform
for the future optimization of scaffolding formulations
and bioprocessing parameters toward the production
of commercially viable osteochondral tissue products
using microfluidic scaffolding strategies.30
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Abbreviations Used
DMEM ¼ Dulbecco’s modified Eagle’s medium
DMSO ¼ dimethyl sulfoxide
FBS ¼ fetal bovine serum
GAG ¼ glycosaminoglycan
GAPDH ¼ glyceraldehyde-3-phosphate dehydrogenase
MSC ¼ mesenchymal stem cell
PSF ¼ penicillin–streptomycin–fungizone
RT-qPCR ¼ quantitative reverse transcription polymerase chain
reaction
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